Ginkgo Bioworks Holdings, Inc.DNA
| Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Cash and cash equivalents | 1,550 | 1,316 | 944 |
---|
Accounts receivable, net | 132 | 81 | 17 |
---|
Cash and cash equivalents | 1,550 | 1,316 | 944 |
---|
Accounts receivable - related parties | 5 | 2 | - |
---|
Accounts receivable, net | 132 | 81 | 17 |
---|
Inventory, net | 3 | 4 | - |
---|
Accounts receivable - related parties | 132 | 81 | 17 |
---|
Prepaid expenses and other current assets | 34 | 47 | 40 |
---|
Total current assets | 1,723 | 1,450 | 1,002 |
---|
Property, plant and equipment, net | 146 | 315 | 188 |
---|
Cash and cash equivalents | 1,550 | 1,316 | 944 |
---|
Accounts receivable, net | 132 | 81 | 17 |
---|
Cash and cash equivalents | 1,550 | 1,316 | 944 |
---|
Accounts receivable - related parties | 5 | 2 | - |
---|
Accounts receivable, net | 132 | 81 | 17 |
---|
Inventory, net | 3 | 4 | - |
---|
Accounts receivable - related parties | 132 | 81 | 17 |
---|
Prepaid expenses and other current assets | 34 | 47 | 40 |
---|
Total current assets | 1,723 | 1,450 | 1,002 |
---|
Operating lease right-of-use assets | - | 401 | 207 |
---|
Property, plant and equipment, net | 146 | 315 | 188 |
---|
Investments | 102 | 112 | - |
---|
Operating lease right-of-use assets | - | 401 | 207 |
---|
Equity Method Investment | 13 | 2 | - |
---|
Investments | - | - | 79 |
---|
Intangible assets, net | 22 | 111 | 83 |
---|
Equity method investments | 13 | 2 | - |
---|
Goodwill | 21 | 60 | 49 |
---|
Intangible assets, net | 22 | 111 | 83 |
---|
Other non-current assets | 44 | 89 | 58 |
---|
Goodwill | 21 | 60 | 49 |
---|
Total assets | 2,071 | 2,539 | 1,665 |
---|
Other non-current assets | 44 | 89 | 58 |
---|
Total assets | 2,071 | 2,539 | 1,665 |
---|
Accounts payable | 8 | 10 | 9 |
---|
Deferred Revenue, Current | 33 | 48 | - |
---|
Accounts payable | 8 | 10 | 9 |
---|
Accrued Liabilities and Other Liabilities | 93 | 115 | 110 |
---|
Contract with Customer, Liability, Current | - | - | 44 |
---|
Total current liabilities | 135 | 173 | 164 |
---|
Accrued Liabilities and Other Liabilities | 93 | 115 | 110 |
---|
Total current liabilities | 135 | 173 | 164 |
---|
Deferred Rent Credit, Noncurrent | 19 | - | - |
---|
Deferred Revenue, Noncurrent | 156 | 175 | - |
---|
Contract with Customer, Liability, Noncurrent | - | - | 158 |
---|
Operating Lease, Liability, Noncurrent | - | 413 | 222 |
---|
Lease financing obligation | 22 | - | - |
---|
Warrant liabilities | 136 | 11 | 6 |
---|
Warrant liabilities | 136 | 11 | 6 |
---|
Other non-current liabilities | 36 | 31 | 19 |
---|
Other non-current liabilities | 36 | 31 | 19 |
---|
Accounts payable | 8 | 10 | 9 |
---|
Deferred Revenue, Current | 33 | 48 | - |
---|
Accounts payable | 8 | 10 | 9 |
---|
Accrued Liabilities and Other Liabilities | 93 | 115 | 110 |
---|
Contract with Customer, Liability, Current | - | - | 44 |
---|
Total current liabilities | 135 | 173 | 164 |
---|
Accrued Liabilities and Other Liabilities | 93 | 115 | 110 |
---|
Total current liabilities | 135 | 173 | 164 |
---|
Total liabilities | 504 | 803 | 568 |
---|
Deferred Rent Credit, Noncurrent | 19 | - | - |
---|
Deferred Revenue, Noncurrent | 156 | 175 | - |
---|
Contract with Customer, Liability, Noncurrent | - | - | 158 |
---|
Operating Lease, Liability, Noncurrent | - | 413 | 222 |
---|
Lease financing obligation | 22 | - | - |
---|
Warrant liabilities | 136 | 11 | 6 |
---|
Warrant liabilities | 136 | 11 | 6 |
---|
Other non-current liabilities | 36 | 31 | 19 |
---|
Other non-current liabilities | 36 | 31 | 19 |
---|
Total liabilities | 504 | 803 | 568 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Additional paid-in capital | 3,805 | 6,136 | 6,386 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Accumulated deficit | -2,298 | -4,398 | -5,291 |
---|
Additional paid-in capital | 3,805 | 6,136 | 6,386 |
---|
Accumulated other comprehensive income (loss) | -2 | -3 | 1 |
---|
Accumulated deficit | -2,298 | -4,398 | -5,291 |
---|
Total Ginkgo Bioworks Holdings, Inc. stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Accumulated other comprehensive income (loss) | -2 | -3 | 1 |
---|
Non-controlling interest | 62 | - | - |
---|
Total stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Total stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Total liabilities and stockholders’ equity | 2,071 | 2,539 | 1,665 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Additional paid-in capital | 3,805 | 6,136 | 6,386 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Accumulated deficit | -2,298 | -4,398 | -5,291 |
---|
Additional paid-in capital | 3,805 | 6,136 | 6,386 |
---|
Accumulated other comprehensive income (loss) | -2 | -3 | 1 |
---|
Accumulated deficit | -2,298 | -4,398 | -5,291 |
---|
Total Ginkgo Bioworks Holdings, Inc. stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Accumulated other comprehensive income (loss) | -2 | -3 | 1 |
---|
Non-controlling interest | 62 | - | - |
---|
Total stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Total stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Total liabilities and stockholders’ equity | 2,071 | 2,539 | 1,665 |
---|
Total liabilities and stockholders’ equity | 2,071 | 2,539 | 1,665 |
---|
Cash and cash equivalents | 1,550 | 1,316 | 944 |
---|
Accounts receivable, net | 132 | 81 | 17 |
---|
Cash and cash equivalents | 1,550 | 1,316 | 944 |
---|
Accounts receivable - related parties | 5 | 2 | - |
---|
Accounts receivable, net | 132 | 81 | 17 |
---|
Inventory, net | 3 | 4 | - |
---|
Accounts receivable - related parties | 132 | 81 | 17 |
---|
Prepaid expenses and other current assets | 34 | 47 | 40 |
---|
Total current assets | 1,723 | 1,450 | 1,002 |
---|
Property, plant and equipment, net | 146 | 315 | 188 |
---|
Cash and cash equivalents | 1,550 | 1,316 | 944 |
---|
Accounts receivable, net | 132 | 81 | 17 |
---|
Cash and cash equivalents | 1,550 | 1,316 | 944 |
---|
Accounts receivable - related parties | 5 | 2 | - |
---|
Accounts receivable, net | 132 | 81 | 17 |
---|
Inventory, net | 3 | 4 | - |
---|
Accounts receivable - related parties | 132 | 81 | 17 |
---|
Prepaid expenses and other current assets | 34 | 47 | 40 |
---|
Total current assets | 1,723 | 1,450 | 1,002 |
---|
Operating lease right-of-use assets | - | 401 | 207 |
---|
Property, plant and equipment, net | 146 | 315 | 188 |
---|
Investments | 102 | 112 | - |
---|
Operating lease right-of-use assets | - | 401 | 207 |
---|
Equity Method Investment | 13 | 2 | - |
---|
Investments | - | - | 79 |
---|
Intangible assets, net | 22 | 111 | 83 |
---|
Equity method investments | 13 | 2 | - |
---|
Goodwill | 21 | 60 | 49 |
---|
Intangible assets, net | 22 | 111 | 83 |
---|
Other non-current assets | 44 | 89 | 58 |
---|
Goodwill | 21 | 60 | 49 |
---|
Total assets | 2,071 | 2,539 | 1,665 |
---|
Other non-current assets | 44 | 89 | 58 |
---|
Total assets | 2,071 | 2,539 | 1,665 |
---|
Accounts payable | 8 | 10 | 9 |
---|
Deferred Revenue, Current | 33 | 48 | - |
---|
Accounts payable | 8 | 10 | 9 |
---|
Accrued Liabilities and Other Liabilities | 93 | 115 | 110 |
---|
Contract with Customer, Liability, Current | - | - | 44 |
---|
Total current liabilities | 135 | 173 | 164 |
---|
Accrued Liabilities and Other Liabilities | 93 | 115 | 110 |
---|
Total current liabilities | 135 | 173 | 164 |
---|
Deferred Rent Credit, Noncurrent | 19 | - | - |
---|
Deferred Revenue, Noncurrent | 156 | 175 | - |
---|
Contract with Customer, Liability, Noncurrent | - | - | 158 |
---|
Operating Lease, Liability, Noncurrent | - | 413 | 222 |
---|
Lease financing obligation | 22 | - | - |
---|
Warrant liabilities | 136 | 11 | 6 |
---|
Warrant liabilities | 136 | 11 | 6 |
---|
Other non-current liabilities | 36 | 31 | 19 |
---|
Other non-current liabilities | 36 | 31 | 19 |
---|
Accounts payable | 8 | 10 | 9 |
---|
Deferred Revenue, Current | 33 | 48 | - |
---|
Accounts payable | 8 | 10 | 9 |
---|
Accrued Liabilities and Other Liabilities | 93 | 115 | 110 |
---|
Contract with Customer, Liability, Current | - | - | 44 |
---|
Total current liabilities | 135 | 173 | 164 |
---|
Accrued Liabilities and Other Liabilities | 93 | 115 | 110 |
---|
Total current liabilities | 135 | 173 | 164 |
---|
Total liabilities | 504 | 803 | 568 |
---|
Deferred Rent Credit, Noncurrent | 19 | - | - |
---|
Deferred Revenue, Noncurrent | 156 | 175 | - |
---|
Contract with Customer, Liability, Noncurrent | - | - | 158 |
---|
Operating Lease, Liability, Noncurrent | - | 413 | 222 |
---|
Lease financing obligation | 22 | - | - |
---|
Warrant liabilities | 136 | 11 | 6 |
---|
Warrant liabilities | 136 | 11 | 6 |
---|
Other non-current liabilities | 36 | 31 | 19 |
---|
Other non-current liabilities | 36 | 31 | 19 |
---|
Total liabilities | 504 | 803 | 568 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Additional paid-in capital | 3,805 | 6,136 | 6,386 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Accumulated deficit | -2,298 | -4,398 | -5,291 |
---|
Additional paid-in capital | 3,805 | 6,136 | 6,386 |
---|
Accumulated other comprehensive income (loss) | -2 | -3 | 1 |
---|
Accumulated deficit | -2,298 | -4,398 | -5,291 |
---|
Total Ginkgo Bioworks Holdings, Inc. stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Accumulated other comprehensive income (loss) | -2 | -3 | 1 |
---|
Non-controlling interest | 62 | - | - |
---|
Total stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Total stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Total liabilities and stockholders’ equity | 2,071 | 2,539 | 1,665 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Additional paid-in capital | 3,805 | 6,136 | 6,386 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 |
---|
Accumulated deficit | -2,298 | -4,398 | -5,291 |
---|
Additional paid-in capital | 3,805 | 6,136 | 6,386 |
---|
Accumulated other comprehensive income (loss) | -2 | -3 | 1 |
---|
Accumulated deficit | -2,298 | -4,398 | -5,291 |
---|
Total Ginkgo Bioworks Holdings, Inc. stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Accumulated other comprehensive income (loss) | -2 | -3 | 1 |
---|
Non-controlling interest | 62 | - | - |
---|
Total stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Total stockholders’ equity | 1,567 | 1,736 | 1,097 |
---|
Total liabilities and stockholders’ equity | 2,071 | 2,539 | 1,665 |
---|
Total liabilities and stockholders’ equity | 2,071 | 2,539 | 1,665 |
---|